Alcon Operating Expenses 2019-2025 | ALC

Alcon operating expenses for the twelve months ending March 31, 2025 were $8.412B, a 0.13% decline year-over-year.

  • Alcon annual operating expenses for 2024 were $8.498B, a 0.97% increase from 2023.
  • Alcon annual operating expenses for 2023 were $8.416B, a 4.61% increase from 2022.
  • Alcon annual operating expenses for 2022 were $8.045B, a 4.33% increase from 2021.

Alcon Operating Expenses 2019-2025 | ALC

  • Alcon annual operating expenses for 2024 were $8.498B, a 0.97% increase from 2023.
  • Alcon annual operating expenses for 2023 were $8.416B, a 4.61% increase from 2022.
  • Alcon annual operating expenses for 2022 were $8.045B, a 4.33% increase from 2021.
Related Stocks
Company NameMarket
Cap
Thermo Fisher Scientific (TMO)$183.1B
Intuitive Surgical (ISRG)$177.1B
Edwards Lifesciences (EW)$46B
IDEXX Laboratories (IDXX)$45.6B
DexCom (DXCM)$35.1B
IQVIA Holdings (IQV)$33.6B
Mettler-Toledo (MTD)$26.2B
STERIS (STE)$22.3B
Waters (WAT)$18B
SONOVA HOLDING (SONVY)$17.3B
Hologic (HOLX)$14.6B
Sysmex ADR (SSMXY)$10.6B
Penumbra (PEN)$8.9B
Masimo (MASI)$8.8B
Globus Medical (GMED)$7.4B
Glaukos (GKOS)$5.4B
Teleflex (TFX)$5.1B
Integer Holdings (ITGR)$3.8B
TransMedics (TMDX)$3.6B
PROCEPT BioRobotics (PRCT)$3B
LivaNova (LIVN)$2.4B
Veracyte (VCYT)$2B
Elekta AB (EKTAY)$1.9B
Nihon Kohden (NHNKY)$1.9B
Alphatec Holdings (ATEC)$1.6B
Artivion (AORT)$1.3B
Tandem Diabetes Care (TNDM)$1.1B
Paragon 28 (FNA)$1.1B
OPKO Health (OPK)$1.1B
Pulse Biosciences (PLSE)$1B